Preformulation Considerations Development and Evaluation of Mesalamine Loaded Polysaccharide-Based Complex Mucoadhesive Beads for Colon Targeting
Open Access
- 19 February 2021
- journal article
- research article
- Published by EManuscript Technologies in Indian Journal of Pharmaceutical Education and Research
- Vol. 55 (1), 95-106
- https://doi.org/10.5530/ijper.55.1.13
Abstract
Background: Inflammatory bowel disease (IBD) is a chronic inflammatory disease of large intestine consisting of ulcerative colitis and Crohn's disease. Mesalamine is a first line drug use for the treatment but it has drawback of low water solubility and low permeability. In addition, oral drug delivery to colon faces the problem of gastric degradation and thus increases dose size and frequency. Objectives: The present study was aimed to assay mesalamine and develop an enteric coated mesalamine loaded mucoadhesive beads using guar gum, sodium alginate and carbopol 940 for an effective delivery to colon. Methods: Preformulation study was done to check the purity of drug. The beads were prepared by ion gelation methods and coated with Eudragit S100 and characterized. Results: The melting point and absorbance maxima of mesalamine were found to be 282 degrees C and 220 nm respectively. The FTIR study confirms the drug and polymers were compatible. A total 5 different formulations were prepared which specifically release the drug in the colon region in sustain release fashion. The formulation MA-F4 was chosen as an optimized formulation. The Particle size, Zeta potential, %EE, %Yield, %DL and in vitro drug release of optimized formulation was found to be 445.6 +/- 67.1 mu m, -28.01 +/- 0.16 mV, 94.98 +/- 3.22, 96.27 +/- 3.22, 30.4 +/- 0.9 and 95.07 +/- 3.85 respectively. Conclusion: The study demonstrated that the prepared beads can release the mesalamine in sustained release manner and helps in management of IBD.Keywords
This publication has 26 references indexed in Scilit:
- Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissueNanomedicine: Nanotechnology, Biology and Medicine, 2015
- Cancer and Immunomodulators in Inflammatory Bowel DiseasesInflammatory Bowel Diseases, 2015
- Treatment of IBD: Where We Are and Where We Are GoingThe American Journal of Gastroenterology, 2015
- Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief reviewSaudi Pharmaceutical Journal, 2014
- Fabrication and in vitro evaluation of mucoadhesive ondansetron hydrochloride beads for the management of emesis in chemotherapyInternational Journal of Pharmaceutical Investigation, 2013
- Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancerPharmaceutical Development and Technology, 2012
- Mesalamine in the treatment and maintenance of remission of ulcerative colitisExpert Review of Clinical Pharmacology, 2012
- Preparation, in vitro and in vivo evaluation of algino-pectinate bioadhesive microspheres: An investigation of the effects of polymers using multiple comparison analysisActa Pharmaceutica, 2010
- Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoateInternational Journal of Pharmaceutics, 2008
- SulfasalazineAnnals of Internal Medicine, 1984